Loading...
OTCM
PHRX
Market cap5kUSD
Nov 03, Last price  
0.00USD
Name

Pharmagen Inc

Chart & performance

D1W1MN
OTCM:PHRX chart
P/E
—
P/S
—
EPS
—
Vol. 1Y
—
Shs. 5Y
—
Rev. 5Y
%
Div Yld LY
—
Div Yld TTM
—
Revenues
0
Net income
0
CFO
0

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Pharmagen, Inc., a pharmaceutical company located in Silver Spring, Maryland, operates primarily as a distributor within the U.S. healthcare market. It provides a diverse range of specialty drugs to various medical clients, including hospitals, acute care centers, surgical facilities, and other healthcare practitioners nationwide. The company's offerings encompass sourcing and distributing specialty pharmaceuticals, blood plasma derivatives, unique medical products, vaccines, anti-infectives, and often hard-to-find medications. A key area of its expertise lies in plasma derivatives, which are vital for managing severe conditions such as cancer, hemophilia, rheumatoid arthritis, multiple sclerosis, blood disorders, hepatitis, and HIV. Additionally, Pharmagen supplies specialized products designed to treat respiratory, oncological, cardiovascular, and hormonal ailments. Beyond its core distribution activities, Pharmagen also produces and sells its own health supplements, notably Clotamin, an over-the-counter multivitamin formulated specifically for individuals undergoing Warfarin therapy. The company further serves its existing customers by supplying traditional pharmaceuticals, including a variety of antibiotics, vaccines, and other oral and injectable medicines. With a specialized focus on drug formulation, Pharmagen Inc. adopted its current name in January 2013, having previously operated as Sunpeaks Ventures, Inc.

Key people

Richard A. Wolpow
Chairman of the Board · since 2014
Mackie A. Barch
Vice Chairman of the Board, Founder · since 2014
Russell L. Skibsted
Chief Financial Officer, Executive Vice President, Principal Financial Officer · since 2014
Boyd P. Relac
Chief Operating Officer · since 2014
Danny Barnes
Director · since 2014
Stephen M. Perry
Director · since 2014
David S. Rowley
Director · since 2014
IPO date
Oct 26, 2011
Employees
24
Domiciled in
US
Incorporated in
US

Valuation

No data to show